Is it too late to buy Origin Energy Limited and Santos Limited?

One of these two stocks still looks like it could be in the buy zone.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recent announcements by both integrated energy provider Origin Energy Limited (ASX: ORG) and oil and gas producer Santos Limited (ASX: STO) are a reminder for investors that a step change in production volumes and revenues for both businesses is about to happen. Despite being widely acknowledged, this perhaps isn't yet fully reflected in their respective share prices.

The recent March quarterly production figures released by Origin show strong production volumes were achieved over the prior quarter. The figures showed that Origin lifted its quarterly production by 10%, thanks largely to increased contributions from its Australia Pacific LNG Project (APLNG) and Otway Project. The 10% jump in volumes filtered through to a hefty 27% increase in revenues, thanks to higher average commodity prices and higher third party sales volumes.

Importantly the market was also provided with an update on the APLNG project. Origin's CEO of LNG, Mr David Baldwin stated that: "APLNG remains on track to deliver first LNG in mid-2015, with the upstream component approximately 67% complete and the downstream component approximately 68% complete."

Meanwhile Santos has just announced to the market that the PNG LNG Project – which Oil Search Limited (ASX: OSH) is also a major shareholder in – has started producing liquefied natural gas (LNG) ahead of schedule.

It's great news for shareholders and should see LNG beginning to be shipped to Asian markets within the next couple of months. Santos' MD David Knox also took the opportunity to reaffirm to the market that the Gladstone LNG (GLNG) Project was on time and on budget, with the first shipment of LNG expected to occur next year.

Foolish takeaway

With Origin's earnings per share (EPS) forecast to jump from 68 cents per share (cps) in FY 2014 to 82 cps in FY 2015 the stock is trading on a prospective price-to-earnings (PE) ratio of 18x, which perhaps looks fully priced. Santos on the other hand, is forecast to see EPS jump from 63 cps to 103 cps by FY 2015, placing the stock on what looks to be a very appealing PE ratio of just 13.3x.

Motley Fool contributor Tim McArthur owns shares in Origin Energy Ltd.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »